Ambrisentan
Product manufactured by Sun Pharmaceutical Industries, Inc.
Indications and Purposes
1 Indications And Usage Ambrisentan Is Indicated For The Treatment Of Pulmonary Arterial Hypertension (Pah) (Who Group 1): • To Improve Exercise Ability And Delay Clinical Worsening. Studies Establishing Effectiveness Included Predominantly Patients With Who Functional Class Ii–iii Symptoms And Etiologies Of Idiopathic Or Heritable Pah (60%) Or Pah Associated With Connective Tissue Diseases (34%). Ambrisentan Is An Endothelin Receptor Antagonist Indicated For The Treatment Of Pulmonary Arterial Hypertension (Pah) (Who Group 1): To Improve Exercise Ability And Delay Clinical Worsening. Studies Establishing Effectiveness Included Trials Predominantly In Patients With Who Functional Class Ii–iii Symptoms And Etiologies Of Idiopathic Or Heritable Pah (60%) Or Pah Associated With Connective Tissue Diseases (34%). |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
Name | Structure | ZINC ID(s) |
---|---|---|
1. Ambrisentan |
|
ZINC538627 |